Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-B9726-100 100 µl $485 
GUCA2A / Guanylin Antibody - Anti-GUCA2A / Guanylin antibody IHC staining of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.  This image was taken for the unconjugated form of this product. Other forms have not been tested.

Polyclonal Rabbit anti‑Human GUCA2A / Guanylin Antibody (aa56‑105, IHC, WB) LS‑B9726

Polyclonal Rabbit anti‑Human GUCA2A / Guanylin Antibody (aa56‑105, IHC, WB) LS‑B9726

Note: This antibody replaces LS-C151258
Antibody:
GUCA2A / Guanylin Rabbit anti-Human Polyclonal (aa56-105) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:
Price
Catalog Number
$485
LS-B9726-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
GUCA2A / Guanylin Rabbit anti-Human Polyclonal (aa56-105) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:

Specifications

Description
Guanylin antibody LS-B9726 is an unconjugated rabbit polyclonal antibody to human Guanylin (GUCA2A) (aa56-105). Validated for IHC and WB. Cited in 1 publication.
Target
Human GUCA2A / Guanylin
Synonyms
GUCA2A | GCAP-I | Guanylate cyclase activator 2A | Guanylin | GUCA2 | STARA
Host
Rabbit
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
Polyclonal
Conjugations
Unconjugated. Also available conjugated with Biotin, FITC, HRP.
Purification
Immunoaffinity purified
Modifications
Unmodified
Immunogen
Synthetic peptide located between aa56-105 of human GUCA2A (Q02747, NP_291031). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Elephant (100%); Galago, Marmoset (92%); Sheep (91%); Mouse, Rat (90%); Horse (84%); Bovine (83%); Pig (81%).
Epitope
aa56-105
Specificity
Human GUCA2A / Guanylin
Applications
  • IHC
  • IHC - Paraffin (5 µg/ml)
  • Western blot (0.2 - 1 µg/ml)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, 0.09% sodium azide, 2% sucrose
Storage
Short term: Store at 2-8°C. Long term: Aliquot and store at -20°C. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About GUCA2A / Guanylin
Q02747 M97496 AAA35915.1

LSBio Ratings

GUCA2A / Guanylin Antibody (aa56-105) for IHC, WB/Western LS-B9726 has an LSBio Rating of
Publications (4)

Publications (1)

Immunohistochemical Staining for Uroguanylin, a Satiety Hormone, is Decreased in Intestinal Tissue Specimens From Female Adolescents With Obesity. Di Guglielmo MD, Perdue L, Adeyemi A, van Golen KL, Corao DU. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 2018 May;21:285-295.

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/26/2024